Quality is our promise.

Call us today! 1-888-502-2050

23

September
2014

category:

503b Compounding

Federal jury indicts NECC pharmacist

A federal grand jury in Massachusetts on Tuesday indicted the pharmacist in charge of sterility at the New England Compounding Center. The indictment follows last week’s arrest of Glenn A. Chin on a charge of one count of mail fraud. There were no additional charges in the indictment. Chin’s arraignment is set for 10 a.m. […]

read more

23

September
2014

category:

503b Compounding

Compounding Pharmacy Recalls Potentially Contaminated Drug Products

A New Jersey-based compounding pharmacy has voluntarily recalled 4 prescription preparations distributed in 4 states due to potential contamination, according to the FDA.   Pharmacy Creations first announced the recall on September 6, 2014, following test results that indicated 4 of its drug product lots “may have the potential of not being sterile,” the company […]

read more

23

September
2014

category:

503b Compounding

Baxter Initiates Voluntary Recall of Potassium Chloride Injection

Baxter International announced on Sept. 16, 2014 that it is voluntarily recalling one lot of Potassium Chloride Injection 10mEq per 100mL, product code 2B0826, lot P318220, NDC #0338-0709-48 distributed to the hospital/pharmacy/nurse level for the treatment of potassium deficiency. The recall is being initiated due to a labeling error on the shipping cartons in a […]

read more